BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17303204)

  • 1. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus.
    Maier CC; Delagrave S; Zhang ZX; Brown N; Monath TP; Pugachev KV; Guirakhoo F
    Virology; 2007 Jun; 362(2):468-74. PubMed ID: 17303204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
    Lee E; Hall RA; Lobigs M
    J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).
    Pugachev KV; Schwaiger J; Brown N; Zhang ZX; Catalan J; Mitchell FS; Ocran SW; Rumyantsev AA; Khromykh AA; Monath TP; Guirakhoo F
    Vaccine; 2007 Sep; 25(37-38):6661-71. PubMed ID: 17693000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus.
    Rumyantsev AA; Zhang ZX; Gao QS; Moretti N; Brown N; Kleanthous H; Delagrave S; Guirakhoo F; Collett MS; Pugachev KV
    Virology; 2010 Jan; 396(2):329-38. PubMed ID: 19913267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE).
    Reid M; Mackenzie D; Baron A; Lehmann N; Lowry K; Aaskov J; Guirakhoo F; Monath TP
    Am J Trop Med Hyg; 2006 Oct; 75(4):659-63. PubMed ID: 17038690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H; Barrett AD
    Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells.
    Mori Y; Yamashita T; Tanaka Y; Tsuda Y; Abe T; Moriishi K; Matsuura Y
    J Virol; 2007 Aug; 81(16):8477-87. PubMed ID: 17553875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence.
    Muylaert IR; Chambers TJ; Galler R; Rice CM
    Virology; 1996 Aug; 222(1):159-68. PubMed ID: 8806496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.
    Wicker JA; Whiteman MC; Beasley DW; Davis CT; Zhang S; Schneider BS; Higgs S; Kinney RM; Barrett AD
    Virology; 2006 Jun; 349(2):245-53. PubMed ID: 16624366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel model for the study of the therapy of flavivirus infections using the Modoc virus.
    Leyssen P; Van Lommel A ; Drosten C; Schmitz H; De Clercq E ; Neyts J
    Virology; 2001 Jan; 279(1):27-37. PubMed ID: 11145886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein.
    Vlaycheva L; Nickells M; Droll DA; Chambers TJ
    Virology; 2004 Sep; 327(1):41-9. PubMed ID: 15327896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1.
    Hall RA; Khromykh AA; Mackenzie JM; Scherret JH; Khromykh TI; Mackenzie JS
    Virology; 1999 Nov; 264(1):66-75. PubMed ID: 10544130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the NS3 gene and 3'-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus.
    Chiou SS; Chen WJ
    Virology; 2001 Oct; 289(1):129-36. PubMed ID: 11601924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
    Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.